Pharmacodynamic Response to Oral Administration of the Selective Toll-like Receptor 8 Agonist GS-9688 in Healthy Volunteers

被引：0
|
作者：
Grant, Ethan [1 ]
Joshi, Adarsh [2 ]
Ayithan, Natarajan [3 ]
Daffis, Stephane [4 ]
Woo, Jacky [5 ]
Lam, Tina [6 ]
Mackman, Richard L. [7 ]
Fletcher, Simon [4 ]
Gaggar, Anuj [5 ]
Lau, Audrey H. [8 ]
Kottilil, Shyamasundaran [3 ]
Poonia, Bhawna [3 ]
机构：
[1] Gilead Sci Inc, Biomarker Sci, 353 Lakeside Dr, Foster City, CA 94404 USA
[2] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
[3] Univ Maryland, Sch Med, Inst Human Virol, Div Clin Care & Res, Baltimore, MD 21201 USA
[4] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA
[5] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[6] Gilead Sci Inc, Biomarker Operat, 353 Lakeside Dr, Foster City, CA 94404 USA
[7] Gilead Sci Inc, Med Chem, 353 Lakeside Dr, Foster City, CA 94404 USA
[8] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
456
引用
收藏
页码：270A / 270A
页数：1
相关论文
共 50 条
  • [1] In vitro and in vivo characterization of the selective toll-like receptor 8 agonist GS-9688
    Daffis, S.
    Ramakrishnan, D.
    Niu, C.
    Zheng, J.
    Santos, R.
    Mish, M.
    Chin, G.
    Aktoudianakis, V.
    Metobo, S.
    Pyun, H-J
    Yu, H.
    Lee, G.
    Palazzo, A.
    Frey, C.
    Pflanz, S.
    Delaney, W. E.
    Fletcher, S. P.
    Mackman, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S694 - S694
  • [2] ASSESSMENT OF DRUG INTERACTION POTENTIAL OF GS-9688, AN ORAL TOLL-LIKE RECEPTOR 8 AGONIST, IN HEALTHY VOLUNTEERS: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY.
    Reyes, M.
    Lutz, J. D.
    Lau, A. H.
    Gaggar, A.
    Grant, E. P.
    Wu, P.
    Ling, J.
    Levy, J.
    Gane, E. J.
    Mathias, A.
    German, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S110 - S110
  • [3] Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
    Mackman, Richard L.
    Mish, Michael
    Chin, Gregory
    Perry, Jason K.
    Appleby, Todd
    Aktoudianakis, Vangelis
    Metobo, Sammy
    Pyun, Peter
    Niu, Congrong
    Daffis, Stephane
    Yu, Helen
    Zheng, Jim
    Villasenor, Armando G.
    Zablocki, Jeff
    Chamberlain, Jason
    Jin, Haolun
    Lee, Gary
    Suekawa-Pirrone, Kimberley
    Santos, Rex
    Delaney, William E.
    Fletcher, Simon P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (18) : 10188 - 10203
  • [4] PERIPHERAL IMMUNE RESPONSES TO TOLL-LIKE RECEPTOR 8 AGONIST GS-9688 IN PATIENTS WITH CHRONIC HEPATITIS B
    Brooks, Anna E.
    Verdon, Daniel
    Eom, Jennifer
    Ng, Jin
    Steemson, John
    Lau, Audrey H.
    Wallin, Jeffrey
    Gaggar, Anuj
    Kottilil, Shyam
    Poonia, Bhawna
    Dunbar, Rod
    HEPATOLOGY, 2019, 70 : 440A - 441A
  • [5] First in Human Study of GS-9688, an Oral Toll-like Receptor 8 (TLR8) Agonist, in Healthy Volunteers: Assessment of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect
    Reyes, Maribel
    Lutz, Justin D.
    Lau, Audrey H.
    Gaggar, Anuj
    Grant, Ethan
    Joshi, Adarsh
    Mackman, Richard L.
    Ling, John
    Mathias, Anita
    German, Polina
    Gane, Edward J.
    HEPATOLOGY, 2018, 68 : 233A - 233A
  • [6] Functional Activation of NK and CD8+ T Cells In Vitro by the Toll-Like Receptor 8 Agonist GS-9688
    Steuer, Holly Micolochick
    Palazzo, Adam
    Peiser, Leanne
    Frey, Christian
    Daffis, Stephane
    Lehar, Sophie M.
    Mackman, Richard L.
    Delaney, William E.
    Fletcher, Simon P.
    HEPATOLOGY, 2017, 66 : 489A - 489A
  • [7] GS-9688, a Toll-like Receptor 8 Agonist Induces Innate and Adaptive Antiviral Immune Response in Chronic Hepatitis B Patients
    Khanam, Arshi
    Yoon, Ji Ae
    Poonia, Bhawna
    Grant, Ethan
    Kottilil, Shyamasundaran
    Tang, Lydia
    HEPATOLOGY, 2018, 68 : 329A - 330A
  • [8] Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
    Daffis, Stephane
    Balsitis, Scott
    Chamberlain, Jason
    Zheng, Jim
    Santos, Rex
    Rowe, William
    Ramakrishnan, Dhivya
    Pattabiraman, Divya
    Spurlock, Sandra
    Chu, Ruth
    Kang, Don
    Mish, Michael
    Ramirez, Ricardo
    Li, Li
    Li, Bei
    Ma, Sarina
    Hung, Magdeleine
    Voitenleitner, Christian
    Yon, Changsuek
    Suresh, Manasa
    Menne, Stephan
    Cote, Paul
    Delaney, William E.
    Mackman, Richard
    Fletcher, Simon P.
    HEPATOLOGY, 2021, 73 (01) : 53 - 67
  • [9] Sustained efficacy and surface antigen seroconversion in the woodchuck model of chronic hepatitis B with the selective toll-like receptor 8 agonist GS-9688
    Daffis, S.
    Chamberlain, J.
    Zheng, J.
    Santos, R.
    Rowe, W.
    Mish, M.
    Ramakrishnan, D.
    Yon, C.
    Suresh, M.
    Menne, S.
    Cote, P.
    Delaney, W. E.
    Fletcher, S. P.
    Mackman, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S692 - S693
  • [10] Cytokines Induced by GS-9688, a Toll-Like Receptor 8 Agonist, Inhibit HBV RNA, DNA and Antigen Levels in Primary Human Hepatocytes
    Niu, Congrong
    Daffis, Stephane
    Mackman, Richard L.
    Delaney, William E.
    Fletcher, Simon P.
    HEPATOLOGY, 2017, 66 : 489A - 489A
12345